CPH
WST icon

C Partners Holding’s West Pharmaceutical WST Stock Holding History

C Partners Holding’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,069
Closed -$132K – 216
2018
Q3 		$132K Sell
1,069
-1,411
-57% -$158K 0.05% 52
2018
Q2 		$246K Buy
2,480
+257
+12% +$23.7K 0.09% 56
2018
Q1 		$196K Sell
2,223
-365
-14% -$34.1K 0.08% 222
2017
Q4 		$255K Buy
+2,588
New +$254K 0.1% 210

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

C Partners Holding's WST Position: Q4 2018 in Review

C Partners Holding sold out of West Pharmaceutical (WST) in Q4 2018, closing a stake of 1,069 shares — an estimated $132K sold.

C Partners Holding first reported a position in WST in Q4 2017 and held it in 4 quarters. The position peaked at $255K in Q4 2017. 355 funds tracked by Wall St. Rank hold WST as of Q4 2018.

  • C Partners Holding reported no remaining West Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 1,069 West Pharmaceutical shares in Q4 2018, an estimated $132K.
  • C Partners Holding first reported a position in West Pharmaceutical in Q4 2017 and held it in 4 quarters.
  • C Partners Holding's West Pharmaceutical position peaked at $255K in Q4 2017.
  • 355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.